1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities
In-Person Event
Apr 27 - 28, 2018
New York, New York, USA
OVERVIEW
1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities is organized by Memorial Sloan Kettering Cancer Center (MSKCC) and will be held during Apr 27 - 28, 2018 at Mortimer B. Zuckerman Research Center, New York, United States of America.
The target audience for this medical event is Bone Marrow Transplant, Cardiology, Gastroenterology, Hematology & Oncology, Infectious Disease, Laboratory Medicine, Medical Oncology, Nephrology, Neurology, Pediatric Oncology, Pulmonary Medicine. his CME Conference has been approved for a maximum of 13.75 AMA PRA Category 1 Credits.
Course Overview:
More than 10,000 hematopoietic cell transplantations (HCT) are performed annually in the United States as a potentially curative treatment for over 70 life-threatening illnesses including hematologic cancers, genetic disorders, and other diseases. Despite significant advances in supportive care and improvements in HCT outcomes, 1 in every 3 patients may succumb to HCT-related toxicities, half of which are not related to graft-versus-host disease (GVHD). Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, we are convening the '1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities.’
This symposium will bring together experts and thought leaders from around the world in the fields of HCT and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT in order to identify best practices to both prevent and treat HCT-related toxicities. Over the 2-day symposium, speakers and attendees will also convene in dedicated sessions that will facilitate collaborative efforts in planning future research aimed at mitigating serious toxicities, reducing symptom burden, and improving patients’ outcomes.
Course Objectives:
Discuss the causes and mechanisms of toxicities and symptom burden after HCT in order to identify best practices to prevent and treat them.
Understand the role of vascular endothelial cell damage as a key driver of many toxicities after HCT.
Additional details will be posted as soon as they are available.
Course Overview:
More than 10,000 hematopoietic cell transplantations (HCT) are performed annually in the United States as a potentially curative treatment for over 70 life-threatening illnesses including hematologic cancers, genetic disorders, and other diseases. Despite significant advances in supportive care and improvements in HCT outcomes, 1 in every 3 patients may succumb to HCT-related toxicities, half of which are not related to graft-versus-host disease (GVHD). Following the successful examples of the international symposia focusing on GVHD and relapse after HCT, we are convening the '1st International Symposium on Hematopoietic Cell Transplantation-Related Toxicities.’
This symposium will bring together experts and thought leaders from around the world in the fields of HCT and related medical subspecialties. Speakers will discuss mechanisms of toxicities and symptom burden after HCT in order to identify best practices to both prevent and treat HCT-related toxicities. Over the 2-day symposium, speakers and attendees will also convene in dedicated sessions that will facilitate collaborative efforts in planning future research aimed at mitigating serious toxicities, reducing symptom burden, and improving patients’ outcomes.
Course Objectives:
Discuss the causes and mechanisms of toxicities and symptom burden after HCT in order to identify best practices to prevent and treat them.
Understand the role of vascular endothelial cell damage as a key driver of many toxicities after HCT.
Additional details will be posted as soon as they are available.
KEY DATES
27 Apr, 2018
Event Start Date
28 Apr, 2018
Event End Date
SPECIALITIES
Critical Care MedicineRespiratory TherapyHematopathologySUGGESTED HOTELS
CONFERENCE VENUE
Memorial Sloan Kettering Cancer Center - Zuckerman Research CenterQuick Links